These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25704591)

  • 21. A highly decreased binding of cyclic adenosine monophosphate to protein kinase A in erythrocyte membranes is specific for active psoriasis.
    Schopf RE; Langendorf Y; Benz RE; Färber L; Benes P
    J Invest Dermatol; 2002 Jul; 119(1):160-5. PubMed ID: 12164939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted 307 nm UVB-phototherapy in psoriasis. A pilot study comparing a 307 nm excimer light with topical dithranol.
    Wollina U; Koch A; Scheibe A; Seme B; Streit I; Schmidt WD
    Skin Res Technol; 2012 May; 18(2):212-8. PubMed ID: 22092772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outpatient treatment with short-contact dithranol. The impact of frequent concentration adjustments.
    de Mare S; Calis N; den Hartog G; van de Kerkhof PC
    Acta Derm Venereol; 1989; 69(5):449-51. PubMed ID: 2572119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved therapeutic performance of dithranol against psoriasis employing systematically optimized nanoemulsomes.
    Raza K; Katare OP; Setia A; Bhatia A; Singh B
    J Microencapsul; 2013; 30(3):225-36. PubMed ID: 23088318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical response and side-effects in the treatment of psoriasis with UV-B and -A novel dithranol formulation.
    Christensen OB; Holst R; Hradil E; Brolund L
    Acta Derm Venereol Suppl (Stockh); 1989; 146():96-100; discussion 101. PubMed ID: 2609898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superimposed linear psoriasis: differential therapeutic response of linear and nonlinear lesions.
    Seitz CS; Garbaraviciene J; Bröcker EB; Hamm H
    Clin Exp Dermatol; 2009 Jul; 34(5):e177-9. PubMed ID: 19094135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An open trial of topical urocanic acid for the treatment of stable plaque psoriasis.
    Vestey JP; Norval M
    Photodermatol Photoimmunol Photomed; 1997; 13(1-2):67-8. PubMed ID: 9361132
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of treatment on quality of life in psoriasis patients.
    Prins M; Krabbe PF; Swinkels QO; de Boo T; van de Kerkhof PC; van der Valk PG
    Acta Derm Venereol; 2005; 85(4):304-10. PubMed ID: 16191850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-contact therapy for psoriasis with 3.9% butantrone (10-butyryl dithranol).
    Remitz A
    Acta Derm Venereol; 1989; 69(4):351-4. PubMed ID: 2568062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum prolactin levels in psoriasis and correlation with cutaneous disease activity.
    Dilmé-Carreras E; Martín-Ezquerra G; Sánchez-Regaña M; Umbert-Millet P
    Clin Exp Dermatol; 2011 Jan; 36(1):29-32. PubMed ID: 20608944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The systemic effect of dithranol treatment in psoriasis.
    Goodfield MJ; Hull SM; Cunliffe WJ
    Acta Derm Venereol; 1994 Jul; 74(4):295-7. PubMed ID: 7976091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A new treatment of outpatient psoriasis: short-term dithranol therapy].
    Schmidli J; Hunziker T; Krebs A
    Ther Umsch; 1986 Feb; 43(2):160-4. PubMed ID: 3961713
    [No Abstract]   [Full Text] [Related]  

  • 33. [Modern psoriasis therapy].
    Mahrle G
    Z Hautkr; 1984 May; 59(10):645-6. PubMed ID: 6741203
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of moderate to severe psoriasis with systemic immunomodulatory therapies: a 5-year experience from two departments of dermatology of Northern France.
    Staumont-Sallé D; Florin V; Cottencin AC; Chaby G; Delaporte E
    J Eur Acad Dermatol Venereol; 2012 Aug; 26(8):1038-9. PubMed ID: 21812831
    [No Abstract]   [Full Text] [Related]  

  • 35. A multicentre general practice study to compare Psoradrate 0.1% and Dithrocream 0.1% in the treatment of chronic psoriasis.
    Budden MG
    J Int Med Res; 1982; 10(1):15-21. PubMed ID: 7037501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of dithranol and butantrone in short contact therapy of psoriasis.
    Göransson A
    Acta Derm Venereol; 1987; 67(2):149-53. PubMed ID: 2438880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A very promising treatment method in psoriasis. Short-term anthralin therapy].
    Kunze J; Petres J
    Fortschr Med; 1981 May; 99(20):761-4. PubMed ID: 7262756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different response rates between palmoplantar involvement and diffuse plaque psoriasis in patients treated with infliximab.
    Brunasso AM; Puntoni M; Delfino C; Massone C
    Eur J Dermatol; 2012; 22(1):133-5. PubMed ID: 22134100
    [No Abstract]   [Full Text] [Related]  

  • 39. Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study.
    Tang MM; Chang CC; Chan LC; Heng A
    Int J Dermatol; 2013 Mar; 52(3):314-22. PubMed ID: 23414155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of psoriasis with dithranol cream in general practice.
    Ellis JP; Hindson TC; Hudson PM; Rhodes EL; Vollum DI; Walker AE
    Practitioner; 1984 Feb; 228(1388):219-26. PubMed ID: 6701151
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.